Tissue-specific expression of the prostatic acid phosphatase promoter constructs

Biochemical and Biophysical Research Communications

Volumn 311, Issue 4, 2003, Pages 864-869

  Shan, Jingdong ^a   Porvari, Katja ^a   Kivinen, Anne ^a   Patrikainen, Lila ^a   Halmekytö, Maria ^b   Jänne, Juhani ^b   Vihko, Pirkko ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Androgen effect; DNA binding sites of prostatic nuclear factor; Prostate specific transcription; Prostatic acid phosphatase gene; Reporter gene analyses; Transgenic mice

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; GENE ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; INTRON; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROTEIN EXPRESSION; REPORTER GENE; SEQUENCE HOMOLOGY; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0242690300     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.10.071     Document Type: Article

References (22)

1. Greenberg N., DeMayo F., Sheppard P., Barrios R., Lebovitz R., Finegold M., Angelopoulou R., Dodd J., Duckworth M., Rosen J. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol. 8:1994;230-239.
2. Patrikainen L., Shan J., Porvari K., Vihko P. Identification of the deoxyribonucleic acid-binding site of a regulatory protein involved in prostate-specific and androgen receptor-dependent gene expression. Endocrinology. 140:1999;2063-2070.
3. Höyhtyä M., Vihko P., Vuolas L., Tryggvason K., Vihko R. High-affinity monoclonal antibodies specific for human prostatic acid phosphatase. Clin. Chem. 33:1987;103-107.
4. Hakalahti L., Vihko P., Henttu P., Autio-Harmainen H., Soini Y., Vihko R. Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using Northern-blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies. Int. J. Cancer. 55:1993;590-597.
5. Lin M., Garcia-Arenas R., Chao Y., Lai M., Patel P., Xia X. Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells. Arch. Biochem. Biophys. 300:1993;384-390.
6. Lin M., Garcia-Arenas R., Kawachi M., Lin F. Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells. Cell. Mol. Biol. Res. 39:1993;739-750.
7. Langeler E., van Uffelen C., Blankenstein M., van Steenbrugge G., Mulder E. Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP. Prostate. 23:1993;213-223.
8. Banas B., Blaschke D., Fittler F., Horz W. Analysis of the promoter of the human prostatic acid phosphatase gene. Biochim. Biophys. Acta. 1217:1994;188-194.
9. Henttu P., Liao C., Vihko P. Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the human prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology. 130:1992;766-772.
10. Shan J., Porvari K., Ruokonen M., Karhu A., Launonen V., Hedberg P., Oikarinen J., Vihko P. Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein. Endocrinology. 138:1997;3764-3770.
11. Virkkunen P., Hedberg P., Palvimo J., Birr E., Porvari K., Ruokonen M., Taavitsainen P., Janne O., Vihko P. Structural comparison of human and rat prostate-specific acid phosphatase genes and their promoters: identification of putative androgen response elements. Biochem. Biophys. Res. Commun. 202:1994;49-57.
12. Porvari K., Kurkela R., Kivinen A., Vihko P. Differential androgen regulation of rat prostatic acid phosphatase transcripts. Biochem. Biophys. Res. Commun. 213:1995;861-868.
13. Zelivianski S., Comeau D., Lin M. Cloning and analysis of the promoter activity of the human prostatic acid phosphatase gene. Biochem. Biophys. Res. Commun. 245:1998;108-112.
14. Zelivianski S., Igawa T., Lim S., Taylor R., Lin M. Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter. Oncogene. 21:2002;3696-3705.
15. Hogan B., Beddington R., Constantini F., Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual. 1994;Cold Spring Harbor, New York.
16. Drews R., Drohan W., Lubon H. Transgene detection in mouse tail digests. Biotechniques. 17:1994;866-867.
17. Davis L., Dibner M., Battey J. Basic Methods in Molecular Biology. 1986;Elsevier, New York.
18. Solin T., Kontturi M., Pohlmann R., Vihko P. Gene expression and prostate specificity of human prostatic acid phosphatase (PAP): evaluation by RNA blot analyses. Biochim. Biophys. Acta. 1048:1990;72-77.
19. Dignam J., Lebovitz R., Roeder R. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
20. Chalbos D., Haagensen D., Parish T., Rochefort H. Identification and androgen regulation of two proteins released by T47D human breast cancer cells. Cancer Res. 47:1987;2787-2792.
21. Cleutjens K., van der Korput H., van Eekelen C., van Rooij H.C., Faber P., Trapman J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 11:1997;148-161.
22. Ghadersohi A., Sood A. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. Clin. Cancer Res. 7:2001;2731-2738.